Interesting. According to this interview, Indonesia approached Recce for the trials/compounds. I expect this will mean no fluffing about, they're in need of a compound that works, and they'll be more than happy to streamline some major tests and research.
Also, considering the enormous and recent $40m Aus tax offset/rebate for overseas research, it quite clearly highlights that a large scale program may soon be underway.
[INTERVIEW] RCE teams with leading Indonesian biomed company for anti-infective push, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.020(6.56%) |
Mkt cap ! $93.72M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 33.0¢ | 30.0¢ | $75.15K | 239.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10934 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |